Experienced in Esophagitis

Bing M. Lu

No. 150 Jimo Road, 
Pudong, CN 
Experienced in Esophagitis
No. 150 Jimo Road, 
Pudong, CN 
OverviewLocationsClinical Research

Overview

Bing Lu practices in Pudong, China. Mr. Lu is rated as an Experienced expert by MediFind in the treatment of Esophagitis. His top areas of expertise are Lung Cancer, Cataract, Non-Small Cell Lung Cancer (NSCLC), Vitrectomy, and Endoscopy.

His clinical research consists of co-authoring 263 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Esophagitis.

Gender
Male

Locations

No. 150 Jimo Road, Pudong, 200120, China
Other Locations
No. 499 Jin Cheng Road, Wuxi, 214023, China
No.100 Hai Ning Road, Shanghai, 200080, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Open-Label, Multicenter, Randomized Study to Investigate the Efficacy and Safety of Tislelizumab (BGB-A317) (Anti-PD1 Antibody) Combined With Platinum-Pemetrexed Versus Platinum-Pemetrexed Alone as First-line Treatment for Patients With Stage IIIB or IV Non-Squamous Non-Small Cell Lung Cancer
A Phase 3, Open-Label, Multicenter, Randomized Study to Investigate the Efficacy and Safety of Tislelizumab (BGB-A317) (Anti-PD1 Antibody) Combined With Platinum-Pemetrexed Versus Platinum-Pemetrexed Alone as First-line Treatment for Patients With Stage IIIB or IV Non-Squamous Non-Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: February 04, 2025
Intervention Type: Drug
Study Drugs: Tislelizumab+Cisplatin or Carboplatin+Pemetrexed, Cisplatin or Carboplatin+Pemetrexed
Study Phase: Phase 3

263 Total Publications

Isolated Nano-Island Catalysts Enable Efficient Double-Bond Migration over Pd Nanoparticles.
Isolated Nano-Island Catalysts Enable Efficient Double-Bond Migration over Pd Nanoparticles.
Journal: ACS nano
Published: December 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lu's expertise for a condition
ConditionClose
      View All 61 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile